Latest On Brainsway Ltd (BWAY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-23 08:01 EST | News | BrainsWay appoints CFO | N/A |  |
| 2023-05-17 13:20 EST | News | Brainsway GAAP EPS of -$0.07 beats by $0.04, revenue of $6.6M beats by $0.2M | N/A | |
| 2023-03-15 22:33 EST | News | Brainsway GAAP EPS of -$0.12 beats by $0.01, revenue of $6.03M misses by $0.27M | N/A | |
| 2023-02-13 16:09 EST | News | BrainsWay appoints CEO | N/A | |
| 2023-01-10 19:03 EST | News | BrainsWay resolves unfair competition litigation with Neuronetics | N/A | |
| 2022-11-17 00:06 EST | News | BrainsWay stock plummets 29% as Q3 loss widens, revenue falls | N/A | |
| 2022-09-14 17:31 EST | News | BrainsWay gets significant private insurance coverage from Cigna for OCD treatment Utilizing Deep TMS | N/A | |
| 2022-08-30 00:21 EST | News | BrainsWay adds 20% on FDA nod for depression therapy | N/A | |
| 2022-08-10 11:26 EST | News | Brainsway GAAP EPS of -$0.07 in-line, revenue of $8.01M misses by $0.41M | N/A | |
| 2022-07-12 21:56 EST | News | BrainsWay's Shares Look Attractive | N/A | |
| 2022-06-28 17:40 EST | News | Brainsway announces insurance coverage by Israeli Ministry of Health | N/A | |
| 2022-05-11 17:49 EST | News | Brainsway GAAP EPS of -$0.06 beats by $0.01, revenue of $8M beats by $0.6M | N/A | |
| 2022-03-09 18:53 EST | News | Brainsway GAAP EPS of -$0.04 beats by $0.02, revenue of $8.47M beats by $0.23M | N/A | |
| 2022-02-01 04:09 EST | News | BrainsWay gets local coverage determination for BrainsWay Deep TMS to treat OCD | N/A | |
| 2022-01-21 22:22 EST | News | BrainsWay's Competitive Advantage Is Growing | N/A | |
| 2021-08-19 00:18 EST | News | BrainsWay shares climb 20% after FDA's Deep TMS system 510k clearance | N/A | |
| 2021-08-11 15:17 EST | News | Brainsway EPS beats by $0.13, beats on revenue | N/A | |
| 2021-07-22 17:41 EST | News | BrainsWay: Still Undervalued (Still) | N/A | |
| 2021-04-30 04:39 EST | News | BrainsWay launches noninvasive treatment for smoking addiction | N/A | |
| 2021-04-26 14:45 EST | News | BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment | N/A | |
| 2021-03-25 08:12 EST | News | Brainsway EPS beats by $0.03, beats on revenue | N/A | |
| 2021-03-02 10:32 EST | Analyst Rating | The Analyst Target Price has increased from $13.19 to $13.38. | Buy | |
| 2021-02-23 08:55 EST | News | BrainsWay readies ADS offering | N/A | |
| 2021-02-18 02:17 EST | Analyst Rating | The Analyst Target Price has increased from $11.94 to $13.19. | Buy | |
| 2021-01-28 10:11 EST | Analyst Rating | The Analyst Target Price has increased from $11.19 to $11.94. | Buy | |
| 2021-01-25 12:19 EST | News | BrainsWay shares fall despite supply deal with Gaelan Medical for Deep TMS | N/A | |
| 2020-12-24 17:54 EST | News | Brainsway: Still Undervalued | N/A | |
| 2020-12-04 06:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 01:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-20 23:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-19 15:47 EST | Analyst Rating | The Analyst Target Price has increased from $11.01 to $11.19. | Buy | |
| 2020-11-19 08:55 EST | News | Brainsway EPS beats by $0.02, beats on revenue | N/A | |
| 2020-11-19 08:55 EST | News | Brainsway +4% on Q3 beat, bottom-line up 66% | N/A | |
| 2020-10-08 21:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-26 05:12 EST | News | Brainsway: Lockdowns Are Hiding Progress In The Business | N/A | |
| 2020-08-25 00:28 EST | News | FDA OKs BrainsWay TMS system for smoking addiction | N/A | |
| 2020-08-15 15:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 19:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 03:32 EST | Analyst Rating | The Analyst Target Price has decreased from $11.26 to $11.01. | Neutral | |
| 2020-08-12 07:51 EST | News | Brainsway EPS beats by $0.09, beats on revenue | N/A | |
| 2020-08-06 16:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:41 EST | Financials | Company financials have been released. | Neutral | |
About Brainsway Ltd (BWAY):
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
General
- Name Brainsway Ltd
- Symbol BWAY
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 107
- Fiscal Year EndDecember
- IPO Date1999-10-06
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryInternet Software & Services (discontinued effective close of September 28, 2018)
- Web URLhttp://www.brainsway.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 4.55
- Price/Book (Most Recent Quarter) 6.87
- Enterprise Value Revenue 5.84
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.05
- Profit Margin -34%
- Operating Margin -25%
- Return on Assets -9%
- Return on Equity -32%
- Revenue 21.28 million
- Earnings Per Share -$1.03
- Revenue Per Share $2.07
- Gross Profit 19.16 million
- Quarterly Earnings Growth 1.4%
View More
Highlights
- Market Capitalization 139.75 million
- EBITDA -4924000
- Analyst Target Price $13.38
- Book Value Per Share $1.77
View More
Share Statistics
- Shares Outstanding 15.88 million
- Shares Float 6.26 million
- % Held by Insiders 289%
- % Held by Institutions 18.18%
- Shares Short 30570
- Shares Short Prior Month 5475
- Short Ratio 0.24
View More
Technicals
- Beta 0.64
- 52 Week High $10.57
- 52 Week Low $5.52
- 50 Day Moving Average 8.74
- 200 Day Moving Average 7.07
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Brainsway Ltd (BWAY) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Brainsway Ltd (BWAY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-18 | $N/A | -$0.04 | -$0.05 | 24.95% |
| 2020-06-30 | 2020-08-12 | $4.82 million | -$0.03 | -$0.12 | 75% |
| 2020-03-31 | 2020-06-24 | $4.16 million | -$0.15 | -$0.15 | 2.15% |
| 2019-12-31 | 2020-03-23 | $6.29 million | -$0.10 | -$0.12 | 13.04% |
| 2019-09-30 | 2019-11-25 | $5.93 million | -$0.12 | -$0.12 | 0% |
| 2019-06-30 | 2019-08-26 | $5.7 million | -$0.17 | -$0.13 | -30.77% |
| 2019-03-31 | 2019-04-17 | $5.18 million | -$0.11 | -$0.14 | 21.43% |
Brainsway Ltd (BWAY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Brainsway Ltd (BWAY) Chart:
Brainsway Ltd (BWAY) News:
Below you will find a list of latest news for Brainsway Ltd (BWAY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Brainsway Ltd (BWAY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest BWAY Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $5.115 |
| Jun 13, 2022 7:59 PM EST | 100 | $5.115 |
| Jun 13, 2022 7:59 PM EST | 100 | $5.115 |
| Jun 13, 2022 7:59 PM EST | 100 | $5.115 |
| Jun 13, 2022 7:59 PM EST | 100 | $5.105 |
Brainsway Ltd (BWAY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-24 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320004547/0001171843-20-004547-index.htm |
| 2020-01-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505065/000089843220000089/0000898432-20-000089-index.htm |
| 2019-04-17 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1505065/000104746919002315/0001047469-19-002315-index.htm |
| 2019-04-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000110465919021835/0001104659-19-021835-index.htm |
| 2019-04-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1505065/000110465919022864/0001104659-19-022864-index.htm |
| 2019-04-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319002535/0001171843-19-002535-index.htm |
| 2019-05-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319003556/0001171843-19-003556-index.htm |
| 2019-05-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319003580/0001171843-19-003580-index.htm |
| 2019-05-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319003660/0001171843-19-003660-index.htm |
| 2019-06-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319004017/0001171843-19-004017-index.htm |
| 2019-06-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319004210/0001171843-19-004210-index.htm |
| 2019-07-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319004634/0001171843-19-004634-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319005483/0001171843-19-005483-index.htm |
| 2019-08-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319005645/0001171843-19-005645-index.htm |
| 2019-09-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319005939/0001171843-19-005939-index.htm |
| 2019-09-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319006000/0001171843-19-006000-index.htm |
| 2019-10-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319006472/0001171843-19-006472-index.htm |
| 2019-10-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319006585/0001171843-19-006585-index.htm |
| 2019-10-31 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319007035/0001171843-19-007035-index.htm |
| 2019-11-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319007548/0001171843-19-007548-index.htm |
| 2019-11-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319007758/0001171843-19-007758-index.htm |
| 2019-11-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319007764/0001171843-19-007764-index.htm |
| 2019-11-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319007768/0001171843-19-007768-index.htm |
| 2019-12-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319007879/0001171843-19-007879-index.htm |
| 2019-12-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184319008022/0001171843-19-008022-index.htm |
| 2020-01-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320000217/0001171843-20-000217-index.htm |
| 2020-02-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320000753/0001171843-20-000753-index.htm |
| 2020-02-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320000808/0001171843-20-000808-index.htm |
| 2020-02-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320000815/0001171843-20-000815-index.htm |
| 2020-03-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320001466/0001171843-20-001466-index.htm |
| 2020-03-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320001628/0001171843-20-001628-index.htm |
| 2020-03-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320001902/0001171843-20-001902-index.htm |
| 2020-04-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320002556/0001171843-20-002556-index.htm |
| 2020-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320003358/0001171843-20-003358-index.htm |
| 2020-05-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320003859/0001171843-20-003859-index.htm |
| 2020-06-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320004253/0001171843-20-004253-index.htm |
| 2020-06-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320004517/0001171843-20-004517-index.htm |
| 2020-06-24 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320004547/0001171843-20-004547-index.htm |
| 2020-07-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320005321/0001171843-20-005321-index.htm |
| 2020-08-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320005839/0001171843-20-005839-index.htm |
| 2020-08-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320006059/0001171843-20-006059-index.htm |
| 2020-09-04 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1505065/000117184320006278/0001171843-20-006278-index.htm |
| 2020-11-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1505065/000117184320007536/0001171843-20-007536-index.htm |
| 2019-05-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505065/000117891319001327/0001178913-19-001327-index.htm |
| 2020-02-18 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505065/000117891320000579/0001178913-20-000579-index.htm |
| 2020-03-23 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1505065/000121390020007056/0001213900-20-007056-index.htm |
| 2019-08-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505065/000149315219013024/0001493152-19-013024-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505065/000149315220002365/0001493152-20-002365-index.htm |
| 2020-10-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1505065/999999999520002886/9999999995-20-002886-index.htm |